AstraZeneca (AZN LN) has overhauled its local management within China, via FT citing sources; Lin is reportedly replacing Lai as general manager in the region among other positional changes

17 Jan 2025 - 13:34- Equities- Source: FT

AstraZeneca PLCPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals (Group)PharmaceuticalsAZN.LNEU SessionUS SessionEU SessionUS SessionEquitiesChinaAZNUnited KingdomNASDAQ 100 IndexFTSE 100 Index

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: